Table 1.

Poly(l-lysine) molecular weight and DNA type affect the body distribution of pLL/DNA complexes in mice

CarcassLiverLungsKidneysIntestineSpleen
pLL20/DNAct 10.8 ± 3.6 78.9 ± 7.3 1.7 ± 0.5 0.8 ± 0.1 1.7 ± 0.7 9.1 ± 4.2 
pLL20/DNAcp 24.5 ± 5.6 60.3 ± 8.5 2.0 ± 0.4 1.9 ± 0.6 4.2 ± 1.1 6.9 ± 1.2 
pLL20/DNAlp 16.3 ± 2.3 71.4 ± 5.2 1.0 ± 0.2 1.8 ± 0.3 4.6 ± 2.3 5.0 ± 1.8 
pLL211/DNAct 36.6 ± 6.8 42.8 ± 8.8 2.8 ± 0.1 1.9 ± 1.0 4.7 ± 1.2 8.8 ± 2.9 
pLL211/DNAcp 33.4 ± 3.2 46.9 ± 3.6 2.9 ± 0.4 1.8 ± 0.4 3.6 ± 0.3 12.5 ± 1.6 
pLL211/DNAlp 30.9 ± 0.8 50.6 ± 2.9 2.5 ± 0.8 1.6 ± 0.4 2.5 ± 0.3 12.1 ± 0.8 
DNA* 9.4 ± 2.9 84.9 ± 2.0 1.1 ± 0.1 6.5 ± 1.8 5.1 ± 1.3 0.4 ± 0.1 
CarcassLiverLungsKidneysIntestineSpleen
pLL20/DNAct 10.8 ± 3.6 78.9 ± 7.3 1.7 ± 0.5 0.8 ± 0.1 1.7 ± 0.7 9.1 ± 4.2 
pLL20/DNAcp 24.5 ± 5.6 60.3 ± 8.5 2.0 ± 0.4 1.9 ± 0.6 4.2 ± 1.1 6.9 ± 1.2 
pLL20/DNAlp 16.3 ± 2.3 71.4 ± 5.2 1.0 ± 0.2 1.8 ± 0.3 4.6 ± 2.3 5.0 ± 1.8 
pLL211/DNAct 36.6 ± 6.8 42.8 ± 8.8 2.8 ± 0.1 1.9 ± 1.0 4.7 ± 1.2 8.8 ± 2.9 
pLL211/DNAcp 33.4 ± 3.2 46.9 ± 3.6 2.9 ± 0.4 1.8 ± 0.4 3.6 ± 0.3 12.5 ± 1.6 
pLL211/DNAlp 30.9 ± 0.8 50.6 ± 2.9 2.5 ± 0.8 1.6 ± 0.4 2.5 ± 0.3 12.1 ± 0.8 
DNA* 9.4 ± 2.9 84.9 ± 2.0 1.1 ± 0.1 6.5 ± 1.8 5.1 ± 1.3 0.4 ± 0.1 

pLL/DNA complexes, formed with pLL20 or pLL211, and either DNAct, DNAcp, or DNAlp were administered into female Balb/c mice (0.1 mL of 10 μg/mL DNA) through tail vein injection. Mice were killed after 30 minutes, and the organs and carcasses were dissolved in 10 M NaOH at 75°C for 1 hour. Radioactivity in the samples was measured in a liquid scintillation analyzer (1900TR; Packard). The values are corrected for the amount of blood present in organs of decapitated mice.36 

pLL indicates poly(l-lysine); DNAct, calf thymus DNA; DNAcp, closed circular plasmid DNA; DNAlp, linear plasmid DNA.

*

DNA value is that obtained after the administration of DNAct and the radioactive probe because there was no significant difference using either DNAcp or DNAlp. Results show the mean ± SD of 3 independent experiments.

Close Modal

or Create an Account

Close Modal
Close Modal